Oncology-adapted magnesium depletion score, C-reactive protein, and health-related quality of life in cancer inpatients: a bibliometric-informed cross-sectional analysis
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Clinical indicators related to magnesium depletion may be associated with systemic inflammation and health-related quality of life (HRQoL) in patients with cancer. This study examined an exploratory oncology-adapted Magnesium Depletion Score (OA-MDS), C-reactive protein (CRP), and statistical indirect associations with SF-12 physical and mental HRQoL. Methods PubMed publications from 2015–2025 were mapped across three pairwise domains linking magnesium depletion, inflammation, and quality of life using CiteSpace publication-trend, keyword co-occurrence, timeline, and burst-term analyses. A hospital-based cross-sectional analysis then examined 1,012 cancer inpatients from a tertiary cancer hospital in Jiangxi Province, China. OA-MDS combined estimated glomerular filtration rate, proton pump inhibitor use, diuretic use, and history of platinum-based chemotherapy. CRP was transformed as lnCRP = ln(CRP + 1). SF-12 physical and mental component summary scores (PCS and MCS) were the outcomes. Adjusted linear regression, restricted cubic splines, and statistical indirect-association models with 5,000 patient-level bootstrap resamples were used. Additional analyses included MUST nutritional risk adjustment, age stratification, and multiple imputation (m = 30; n = 1,455). Results The prespecified searches included 6,222 inflammation–quality of life records, 113 magnesium depletion–inflammation records, and 41 magnesium depletion–quality of life records. Publications increased across all three domains. The inflammation–quality of life literature covered broad clinical and symptom-management themes; magnesium-related themes centered on treatment, nutrition, fatigue, and sleep. Each one-point increase in OA-MDS was associated with a 0.072-unit higher lnCRP (HC3 95% CI : 0.004 to 0.139; P = 0.038). The indirect associations through lnCRP were −0.124 for PCS (95% bootstrap CI : −0.251 to −0.005) and −0.034 for MCS (−0.079 to −0.001). With additional MUST adjustment, the corresponding estimates were −0.123 (−0.240 to −0.016) and −0.030 (−0.075 to −0.001). In the primary MI comparison, the estimates were −0.112 (95% CI : −0.219 to −0.006) for PCS and −0.032 (−0.068 to 0.004) for MCS. Conclusions Higher OA-MDS was associated with higher lnCRP and negative statistical indirect associations with physical and mental HRQoL in the complete-case analysis. The associations persisted after adjustment for MUST nutritional risk. These findings support prospective investigation of magnesium-related risk indicators and inflammation in supportive oncology care.
Source: Frontiers in Oncology
Authors: Kewen Liu(Data curation, Formal analysis, Visualization, Writing – original draft, Writing – review & editing), Mingming Luo(Conceptualization, Data curation, Funding acquisition, Resources, Writing – review & editing), Linmei Guo(Data curation, Investigation, Writing – review & editing), Wentao Tan(Methodology, Writing – review & editing), Huiqing Zhang(Conceptualization, Writing – review & editing), Qi Wang(Formal analysis, Funding acquisition, Validation, Writing – review & editing)
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Keywords: hypomagnesemia, magnesium depletion score, C-reactive protein, systemic inflammation, health-related quality of life, oncology inpatients, SF-12, indirect association, proton pump inhibitors, diuretics, platinum-based chemotherapy, nutritional risk, bibliometric analysis, publication trends, keyword co-occurrence, bootstrapping, restricted cubic splines, multiple imputation
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236172163
